Industry: Pharma & Healthcare
Published Date: 2026-01-04
Pages: 114 Pages
Report ld: 5558914
Request Sample
Customized Report
The global Chondroitin market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be sulfated in variable positions and quantities. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis.
Global Chondroitin Sulfate key players include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, etc. Global top five manufacturers hold a share over 25%.
China is the largest market, with a share over 75%, followed by Europe and North America, both have a share over 10%.
In terms of product, Food Grade is the largest segment, with a share over 70%.
The global Chondroitin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Chondroitin sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Chondroitin manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Chondroitin product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Chondroitin value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Chondroitin Product Scope
1.2 Chondroitin by Type
1.2.1 Global Chondroitin Sales by Type (2021, 2025 & 2032)
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.3 Chondroitin by Application
1.3.1 Global Chondroitin Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Pharmacy
1.3.3 Health Products
1.4 Global Chondroitin Market Estimates and Forecasts (2021-2032)
1.4.1 Global Chondroitin Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Chondroitin Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Chondroitin Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Chondroitin Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Chondroitin Historical Market Scenario by Region (2021-2026)
2.2.1 Global Chondroitin Sales Market Share by Region (2021-2026)
2.2.2 Global Chondroitin Revenue Market Share by Region (2021-2026)
2.3 Global Chondroitin Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Chondroitin Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Chondroitin Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Chondroitin Market Size and Prospects (2021-2032)
2.4.2 Europe Chondroitin Market Size and Prospects (2021-2032)
2.4.3 China Chondroitin Market Size and Prospects (2021-2032)
2.4.4 Japan Chondroitin Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Chondroitin Historical Market Review by Type (2021-2026)
3.1.1 Global Chondroitin Sales by Type (2021-2026)
3.1.2 Global Chondroitin Revenue by Type (2021-2026)
3.1.3 Global Chondroitin Average Price by Type (2021-2026)
3.2 Global Chondroitin Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Chondroitin Sales Forecast by Type (2027-2032)
3.2.2 Global Chondroitin Revenue Forecast by Type (2027-2032)
3.2.3 Global Chondroitin Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Chondroitin
4 Global Market Size by Application
4.1 Global Chondroitin Historical Market Review by Application (2021-2026)
4.1.1 Global Chondroitin Sales by Application (2021-2026)
4.1.2 Global Chondroitin Revenue by Application (2021-2026)
4.1.3 Global Chondroitin Average Price by Application (2021-2026)
4.2 Global Chondroitin Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Chondroitin Sales Forecast by Application (2027-2032)
4.2.2 Global Chondroitin Revenue Forecast by Application (2027-2032)
4.2.3 Global Chondroitin Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Chondroitin Applications
5 Competition Landscape by Players
5.1 Global Chondroitin Sales by Player (2021-2026)
5.2 Global Top Chondroitin Players by Revenue (2021-2026)
5.3 Global Chondroitin Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Chondroitin revenue as of 2025
5.4 Global Chondroitin Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Chondroitin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Chondroitin, Product Type & Application
5.7 Global Key Manufacturers of Chondroitin, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Chondroitin Sales by Company
6.1.1.1 North America Chondroitin Sales by Company (2021-2026)
6.1.1.2 North America Chondroitin Revenue by Company (2021-2026)
6.1.2 North America Chondroitin Sales Breakdown by Type (2021-2026)
6.1.3 North America Chondroitin Sales Breakdown by Application (2021-2026)
6.1.4 North America Chondroitin Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Chondroitin Sales by Company
6.2.1.1 Europe Chondroitin Sales by Company (2021-2026)
6.2.1.2 Europe Chondroitin Revenue by Company (2021-2026)
6.2.2 Europe Chondroitin Sales Breakdown by Type (2021-2026)
6.2.3 Europe Chondroitin Sales Breakdown by Application (2021-2026)
6.2.4 Europe Chondroitin Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Chondroitin Sales by Company
6.3.1.1 China Chondroitin Sales by Company (2021-2026)
6.3.1.2 China Chondroitin Revenue by Company (2021-2026)
6.3.2 China Chondroitin Sales Breakdown by Type (2021-2026)
6.3.3 China Chondroitin Sales Breakdown by Application (2021-2026)
6.3.4 China Chondroitin Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Chondroitin Sales by Company
6.4.1.1 Japan Chondroitin Sales by Company (2021-2026)
6.4.1.2 Japan Chondroitin Revenue by Company (2021-2026)
6.4.2 Japan Chondroitin Sales Breakdown by Type (2021-2026)
6.4.3 Japan Chondroitin Sales Breakdown by Application (2021-2026)
6.4.4 Japan Chondroitin Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 SANXIN
7.1.1 SANXIN Company Information
7.1.2 SANXIN Business Overview
7.1.3 SANXIN Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.1.4 SANXIN Chondroitin Products Offered
7.1.5 SANXIN Recent Development
7.2 Focus Chem
7.2.1 Focus Chem Company Information
7.2.2 Focus Chem Business Overview
7.2.3 Focus Chem Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Focus Chem Chondroitin Products Offered
7.2.5 Focus Chem Recent Development
7.3 GGI
7.3.1 GGI Company Information
7.3.2 GGI Business Overview
7.3.3 GGI Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.3.4 GGI Chondroitin Products Offered
7.3.5 GGI Recent Development
7.4 Guanglong Biochem
7.4.1 Guanglong Biochem Company Information
7.4.2 Guanglong Biochem Business Overview
7.4.3 Guanglong Biochem Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Guanglong Biochem Chondroitin Products Offered
7.4.5 Guanglong Biochem Recent Development
7.5 Hengjie Bio-Pharmaceuticals
7.5.1 Hengjie Bio-Pharmaceuticals Company Information
7.5.2 Hengjie Bio-Pharmaceuticals Business Overview
7.5.3 Hengjie Bio-Pharmaceuticals Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Hengjie Bio-Pharmaceuticals Chondroitin Products Offered
7.5.5 Hengjie Bio-Pharmaceuticals Recent Development
7.6 Huiwen
7.6.1 Huiwen Company Information
7.6.2 Huiwen Business Overview
7.6.3 Huiwen Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Huiwen Chondroitin Products Offered
7.6.5 Huiwen Recent Development
7.7 ISBA
7.7.1 ISBA Company Information
7.7.2 ISBA Business Overview
7.7.3 ISBA Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.7.4 ISBA Chondroitin Products Offered
7.7.5 ISBA Recent Development
7.8 Jiaixng Hengjie
7.8.1 Jiaixng Hengjie Company Information
7.8.2 Jiaixng Hengjie Business Overview
7.8.3 Jiaixng Hengjie Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Jiaixng Hengjie Chondroitin Products Offered
7.8.5 Jiaixng Hengjie Recent Development
7.9 Meitek
7.9.1 Meitek Company Information
7.9.2 Meitek Business Overview
7.9.3 Meitek Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Meitek Chondroitin Products Offered
7.9.5 Meitek Recent Development
7.10 Nippon Zoki
7.10.1 Nippon Zoki Company Information
7.10.2 Nippon Zoki Business Overview
7.10.3 Nippon Zoki Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Nippon Zoki Chondroitin Products Offered
7.10.5 Nippon Zoki Recent Development
7.11 Pacific Rainbow
7.11.1 Pacific Rainbow Company Information
7.11.2 Pacific Rainbow Business Overview
7.11.3 Pacific Rainbow Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Pacific Rainbow Chondroitin Products Offered
7.11.5 Pacific Rainbow Recent Development
7.12 Qingdao Green-Extract
7.12.1 Qingdao Green-Extract Company Information
7.12.2 Qingdao Green-Extract Business Overview
7.12.3 Qingdao Green-Extract Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Qingdao Green-Extract Chondroitin Products Offered
7.12.5 Qingdao Green-Extract Recent Development
7.13 QJBCHINA
7.13.1 QJBCHINA Company Information
7.13.2 QJBCHINA Business Overview
7.13.3 QJBCHINA Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.13.4 QJBCHINA Chondroitin Products Offered
7.13.5 QJBCHINA Recent Development
7.14 Runxin Biotechnology
7.14.1 Runxin Biotechnology Company Information
7.14.2 Runxin Biotechnology Business Overview
7.14.3 Runxin Biotechnology Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Runxin Biotechnology Chondroitin Products Offered
7.14.5 Runxin Biotechnology Recent Development
7.15 SANXIN GROUP
7.15.1 SANXIN GROUP Company Information
7.15.2 SANXIN GROUP Business Overview
7.15.3 SANXIN GROUP Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.15.4 SANXIN GROUP Chondroitin Products Offered
7.15.5 SANXIN GROUP Recent Development
7.16 Shandong Dongcheng
7.16.1 Shandong Dongcheng Company Information
7.16.2 Shandong Dongcheng Business Overview
7.16.3 Shandong Dongcheng Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Shandong Dongcheng Chondroitin Products Offered
7.16.5 Shandong Dongcheng Recent Development
7.17 Sioux Pharm
7.17.1 Sioux Pharm Company Information
7.17.2 Sioux Pharm Business Overview
7.17.3 Sioux Pharm Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Sioux Pharm Chondroitin Products Offered
7.17.5 Sioux Pharm Recent Development
7.18 Summit Nutritionals
7.18.1 Summit Nutritionals Company Information
7.18.2 Summit Nutritionals Business Overview
7.18.3 Summit Nutritionals Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Summit Nutritionals Chondroitin Products Offered
7.18.5 Summit Nutritionals Recent Development
7.19 TSI Group
7.19.1 TSI Group Company Information
7.19.2 TSI Group Business Overview
7.19.3 TSI Group Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.19.4 TSI Group Chondroitin Products Offered
7.19.5 TSI Group Recent Development
7.20 WanTuMing Biological
7.20.1 WanTuMing Biological Company Information
7.20.2 WanTuMing Biological Business Overview
7.20.3 WanTuMing Biological Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.20.4 WanTuMing Biological Chondroitin Products Offered
7.20.5 WanTuMing Biological Recent Development
7.21 Yantai Dongcheng
7.21.1 Yantai Dongcheng Company Information
7.21.2 Yantai Dongcheng Business Overview
7.21.3 Yantai Dongcheng Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.21.4 Yantai Dongcheng Chondroitin Products Offered
7.21.5 Yantai Dongcheng Recent Development
7.22 YBCC
7.22.1 YBCC Company Information
7.22.2 YBCC Business Overview
7.22.3 YBCC Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.22.4 YBCC Chondroitin Products Offered
7.22.5 YBCC Recent Development
7.23 Yibao Group
7.23.1 Yibao Group Company Information
7.23.2 Yibao Group Business Overview
7.23.3 Yibao Group Chondroitin Sales, Revenue and Gross Margin (2021-2026)
7.23.4 Yibao Group Chondroitin Products Offered
7.23.5 Yibao Group Recent Development
8 Chondroitin Manufacturing Cost Analysis
8.1 Chondroitin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Chondroitin
8.4 Chondroitin Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Chondroitin Distributors List
9.3 Chondroitin Customers
10 Chondroitin Market Dynamics
10.1 Chondroitin Industry Trends
10.2 Chondroitin Market Drivers
10.3 Chondroitin Market Challenges
10.4 Chondroitin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Chondroitin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 2900.00
(Single User License)
The global market for Chondroitin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 168
USD 3950.00
(Single User License)
The global Chondroitin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 195
USD 4900.00
(Single User License)
In 2024, the global market size of Chondroitin was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 188
USD 5900.00
(Single User License)
The global Chondroitin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 115
USD 4250.00
(Single User License)
The global market for Chondroitin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 165
USD 3950.00
(Single User License)
The global market for Chondroitin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 116
USD 2900.00
(Single User License)
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Published Date: 2024-04-17
Pages: 201
USD 5600.00
(Single User License)
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Published Date: 2024-04-16
Pages: 193
USD 5900.00
(Single User License)
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Published Date: 2024-04-07
Pages: 128
USD 4900.00
(Single User License)
The global Chondroitin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 138
The global market for Chondroitin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 168
The global Chondroitin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 195
In 2024, the global market size of Chondroitin was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 188
The global Chondroitin market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 115
The global market for Chondroitin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 165
The global market for Chondroitin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 116
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Published: 2024-04-17
Pages: 201
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Published: 2024-04-16
Pages: 193
Chondroitin is a chondrin derivative, generally is Chondroitin sulfate.
Published: 2024-04-07
Pages: 128
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now